Literature DB >> 21093479

Topographical distribution of antimicrobial genes in the zebrafish intestine.

Stefan H Oehlers1, Maria Vega Flores, Tony Chen, Chris J Hall, Kathryn E Crosier, Philip S Crosier.   

Abstract

The zebrafish is increasingly being utilized to study aspects of the conserved innate intestinal immunity of vertebrates. In mammals, some antimicrobial proteins are synthesised by specialised immune cells that appear to have no equivalent in zebrafish. To delineate foci of antimicrobial protein production along the zebrafish intestine, we examined the antero-posterior expression gradients of antimicrobial genes. Quantitative PCR revealed distinct expression gradient profiles, with the mid-intestine exhibiting elevated expression of several genes such as dual oxidase and the defensin beta-like and peptidoglycan recognition protein families. This region also presented with the most numbers of leukocytes and endocytic cells, supporting a specialised immunological role. Conversely, expression of the Dr-RNase family was prominent in the anterior intestine. Expression of the zebrafish β-defensin family was examined in adult zebrafish tissues. Strong expression of defensin beta-like 1 was detected in the swim bladder of zebrafish from the larval stage of development through to adults.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093479     DOI: 10.1016/j.dci.2010.11.008

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  25 in total

1.  Epithelial delamination is protective during pharmaceutical-induced enteropathy.

Authors:  Scott T Espenschied; Mark R Cronan; Molly A Matty; Olaf Mueller; Matthew R Redinbo; David M Tobin; John F Rawls
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-07       Impact factor: 11.205

2.  Culturable gut microbiota diversity in zebrafish.

Authors:  Leon Cantas; Jan Roger Torp Sørby; Peter Aleström; Henning Sørum
Journal:  Zebrafish       Date:  2012-03       Impact factor: 1.985

3.  Inflammatory diseases modelling in zebrafish.

Authors:  Camila Idelí Morales Fénero; Alicia Angelina Colombo Flores; Niels Olsen Saraiva Câmara
Journal:  World J Exp Med       Date:  2016-02-20

Review 4.  The zebrafish as a model for gastrointestinal tract-microbe interactions.

Authors:  Erika M Flores; Anh T Nguyen; Max A Odem; George T Eisenhoffer; Anne Marie Krachler
Journal:  Cell Microbiol       Date:  2020-01-07       Impact factor: 3.715

5.  Effect of Lactobacillus casei on Innate Immunity Responses and Aeromonas hydrophila Resistance in Shabot, Tor grypus.

Authors:  Takavar Mohammadian; Abdolhossein Jangaran-Nejad; Mehrzad Mesbah; Tahereh Shirali; Pedram Malekpouri; Mohammad-Reza Tabandeh
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

6.  Modeling mucosal candidiasis in larval zebrafish by swimbladder injection.

Authors:  Remi L Gratacap; Audrey C Bergeron; Robert T Wheeler
Journal:  J Vis Exp       Date:  2014-11-27       Impact factor: 1.355

Review 7.  Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish.

Authors:  Ye Yang; Sarah Tomkovich; Christian Jobin
Journal:  Inflamm Bowel Dis       Date:  2014-05       Impact factor: 5.325

8.  A defective interleukin-17 receptor A1 causes weight loss and intestinal metabolism-related gene downregulation in Japanese medaka, Oryzias latipes.

Authors:  Yo Okamura; Hiroshi Miyanishi; Masato Kinoshita; Tomoya Kono; Masahiro Sakai; Jun-Ichi Hikima
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

9.  Zebrafish harbor diverse intestinal macrophage populations including a subset intimately associated with enteric neural processes.

Authors:  Christina L Graves; Angela Chen; Victoria Kwon; Celia E Shiau
Journal:  iScience       Date:  2021-05-03

10.  A novel beta-defensin antimicrobial peptide in Atlantic cod with stimulatory effect on phagocytic activity.

Authors:  Jareeporn Ruangsri; Yoichiro Kitani; Viswanath Kiron; Jep Lokesh; Monica F Brinchmann; Bård Ove Karlsen; Jorge M O Fernandes
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.